Given the published evidence of dominant involvement of temporal and parietal brain regions in early neurodegeneration, tau pathology, and neuroinflammation in Alzheimer’s disease (Garibotto et al., 2017; Jagust, 2018; Whitwell, 2018), we decided a priori to focus our analyses on these regions. The gene discussed is MAPT; the disease is Alzheimer disease.